Page 2 - Danielle Stanisic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Danielle stanisic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Danielle Stanisic Today - Breaking & Trending Today

Griffith University: Griffith University researchers develop vaccine for human babesiosis

Share
In a world-first, Griffith University researchers have developed a new vaccine in pre-clinical studies to treat human babesiosis, a tick-transmitted disease closely related to malaria.
Lead researcher Professor Michael Good AO, said the research team including PhD candidate Hanan Al-Nazal and researcher Dr Danielle Stanisic, developed a whole parasite Babesia vaccine that acts as a universal vaccine, inducing immunity against different human Babesia species.
“Babesiosis affects the red blood cells similar to malaria in humans and animals and presents as a flu-like illness and anaemia. People most at risk of severe disease are the elderly, the immunosuppressed and those without spleens. It also affects those who need blood transfusions,’’ Professor Good said. ....

Hanan Al Nazal , Danielle Stanisic , Griffith University , Institute For Glycomics Professor Mark Von Itzstein , Professor Michael Good , Professor Good , Glycomics Professor Mark , கிரிஃபித் பல்கலைக்கழகம் , ப்ரொஃபெஸர் மைக்கேல் நல்ல , ப்ரொஃபெஸர் நல்ல ,

Researchers develop vaccine for human babesiosis

Babesia parasites inside red blood cell.
Griffith University researchers have developed a new vaccine in pre-clinical studies to treat human babesiosis, a tick-transmitted disease closely related to malaria.
Lead researcher Professor Michael Good AO, said the research team including PhD candidate Hanan Al-Nazal and researcher Dr Danielle Stanisic, developed a whole parasite Babesia vaccine that acts as a universal vaccine, inducing immunity against different human Babesia species.
“Babesiosis affects the red blood cells similar to malaria in humans and animals and presents as a flu-like illness and anaemia. People most at risk of severe disease are the elderly, the immunosuppressed and those without spleens. It also affects those who need blood transfusions,” Professor Good said. ....

Hanan Al Nazal , Danielle Stanisic , Griffith University , Institute For Glycomics Professor Mark Von Itzstein , University Of Queensland , Drug Administration , Professor Michael Good , Glycomics Professor Mark , Cell Host , கிரிஃபித் பல்கலைக்கழகம் , பல்கலைக்கழகம் ஆஃப் குயின்ஸ்லாந்து , ப்ரொஃபெஸர் மைக்கேல் நல்ல , செல் தொகுப்பாளர் ,

Australia: Researchers develop vaccine in pre-clinical studies for human babesiosis

Image/CDC
Lead researcher Professor Michael Good AO, said the research team including PhD candidate Hanan Al-Nazal and researcher Dr Danielle Stanisic, developed a whole parasite
Babesia vaccine that acts as a universal vaccine, inducing immunity against different human
Babesia species.
“Babesiosis affects the red blood cells similar to malaria in humans and animals and presents as a flu-like illness and anaemia. People most at risk of severe disease are the elderly, the immunosuppressed and those without spleens. It also affects those who need blood transfusions,’’ Professor Good said.
“In pre-clinical studies we have shown this vaccine can kill the parasite and induce a protective immune response. The immune response is tied to two crucial aspects of the immune system – T Cells and macrophages (which clear bacteria and other germs).” ....

Hanan Al Nazal , Danielle Stanisic , Griffith University , Professor Michael Good , Professor Good , கிரிஃபித் பல்கலைக்கழகம் , ப்ரொஃபெஸர் மைக்கேல் நல்ல , ப்ரொஃபெஸர் நல்ல ,